RT @VeronaPharma: Today, Verona published a review paper in the @COPDJournal summarizing key results from its Phase 1 and 2 studies of inve…
RT @VeronaPharma: Today, Verona published a review paper in the @COPDJournal summarizing key results from its Phase 1 and 2 studies of inve…
RT @VeronaPharma: Today, Verona published a review paper in the @COPDJournal summarizing key results from its Phase 1 and 2 studies of inve…
RT @VeronaPharma: Today, Verona published a review paper in the @COPDJournal summarizing key results from its Phase 1 and 2 studies of inve…
https://t.co/O6FjQBDbmL Ensifentrine is currently in late-stage clinical development for the maintenance treatment of #COPD. This review summarizes non-clinical data as well as Phase 1 and Phase 2 efficacy and safety results of nebulized ensifentrine relev
$VRNA
Today, Verona published a review paper in the @COPDJournal summarizing key results from its Phase 1 and 2 studies of investigational drug #ensifentrine, a potential novel addition to treatment options available for #COPD patients. Read more: https://t.co/E